Thromb Haemost 1965; 14(03/04): 562-579
DOI: 10.1055/s-0038-1654890
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

The Mechanism of Activation of Cat Plasma by Streptokinase*

G Mootse1
1   Division of Experimental Surgery and Physiology, Sloan-Kettering Institute for Cancer Research; Cornell University Medical College, New York, N. Y. and the University of Newcastle Upon Tyne, England
,
L.B Fleming2
1   Division of Experimental Surgery and Physiology, Sloan-Kettering Institute for Cancer Research; Cornell University Medical College, New York, N. Y. and the University of Newcastle Upon Tyne, England
,
E.E Cliffton3
1   Division of Experimental Surgery and Physiology, Sloan-Kettering Institute for Cancer Research; Cornell University Medical College, New York, N. Y. and the University of Newcastle Upon Tyne, England
› Author Affiliations
This work supported by grant # C3817 of the N.C.I. , # HE2867 of the N.H.I. and institutional funds.
Further Information

Publication History

Publication Date:
24 July 2018 (online)

Summary

1. The mechanism involved in the inactivation of cat plasma, serum, and plasma euglobulin by different concentrations of SK has been demonstrated.

2. Two different caseinolytic entities were graphically differentiated. They were characterized by their time of formation and stability studies.

3. With suboptimal SK concentration the development of the caseinolytic activity consisted of an initial rapid phase, followed by a slowly rising activity ; beta plasmin. With optimal SK concentration only the initial rapid caseinolytic activity was obtained (alpha plasmin).

4. It is suggested that beta plasmin was formed by a reversible reaction and was inactivated when substrate was not present. With increasing SK concentration alpha plasmin formation competed with the beta plasmin formation.

5. A comparison of potential caseinolytic activity of cat plasma, serum, and plasma euglobulin to beta and alpha plasmin is present.

1 Research Associate, Sloan-Kettering Institute for Cancer R esearch.


2 Visiting Research Fellow, Sloan-Kettering Institute for Cancer Research; Sr.Registrar, Dept. of Surgery. The University of Newcastle Upon T yne, England.


3 Associate Professor Clinical Surgery, Cornell University Medical College; Associate Member, Sloan-Kettering Institute.